Recently, small-molecule compounds have been discovered that specifically bind to the IR and augment IR-dependent signal transduction cascade, thereby mimicking the action of insulin and could be useful in the treatment of type 2 diabetes [32]. The gene discussed is INS; the disease is type 2 diabetes mellitus.